PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $291,000 | -12.3% | 76,813 | +17.7% | 0.01% | +25.0% |
| Q4 2019 | $332,000 | -0.9% | 65,259 | -1.7% | 0.00% | -20.0% |
| Q3 2019 | $335,000 | +88.2% | 66,377 | +129.6% | 0.01% | +66.7% |
| Q2 2019 | $178,000 | +34.8% | 28,907 | +1.4% | 0.00% | +50.0% |
| Q1 2019 | $132,000 | +11.9% | 28,497 | +0.7% | 0.00% | 0.0% |
| Q4 2018 | $118,000 | -30.6% | 28,287 | +3.9% | 0.00% | -33.3% |
| Q3 2018 | $170,000 | -11.9% | 27,227 | +12.9% | 0.00% | 0.0% |
| Q2 2018 | $193,000 | +14.9% | 24,107 | +6.6% | 0.00% | 0.0% |
| Q1 2018 | $168,000 | +104.9% | 22,617 | +62.7% | 0.00% | +50.0% |
| Q4 2017 | $82,000 | -19.6% | 13,897 | 0.0% | 0.00% | -60.0% |
| Q3 2017 | $102,000 | +9.7% | 13,897 | +1.2% | 0.01% | -16.7% |
| Q2 2017 | $93,000 | +27.4% | 13,727 | +76.7% | 0.01% | +20.0% |
| Q1 2017 | $73,000 | – | 7,770 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|